HGF gene therapy (University of Pittsburgh)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHGF gene therapy (University of Pittsburgh)
Drug Alias Namehepatocyte growth factor gene therapy (University of Pittsburgh)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionHepatocyte growth factor modulators
TargetsHepatocyte growth factor
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Pittsburgh
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantation

Other Information

ATC CodeN/A
Related LinksN/A